IFNG and neoplasm: Although the PBMC and tumor cells were from different dogs, and thus the dog lymphocyte antigen (DLA) was not matched between the cPBMCs and K9TCC cells, the 12C chimeric antibody enhanced tumor cell killing activity and IFNγ secretion (Fig. 5M and N).